United Guardian (UG) EBT Growth (5y) (2015 - 2026)
Powered by 
Analysis
United Guardian (UG) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.59% |
| Mar 31, 2026 | -7.09% |
| Dec 31, 2025 | 1.54% |
| Sep 30, 2025 | -18.46% |
| Jun 30, 2025 | -12.02% |
| Mar 31, 2025 | -6.64% |
| Dec 31, 2024 | -18.44% |
| Sep 30, 2024 | -4.14% |
| Jun 30, 2024 | -2.29% |
| Mar 31, 2024 | -5.50% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | -13.93% |
| Jun 30, 2023 | -19.92% |
| Mar 31, 2023 | -6.63% |
| Dec 31, 2022 | -10.15% |
| Sep 30, 2022 | -22.80% |
| Jun 30, 2022 | -13.02% |
| Mar 31, 2022 | 4.53% |
| Dec 31, 2021 | 6.33% |
| Sep 30, 2021 | -0.39% |